SP will soon explode!!!Fully funded & in collaboration with UofM. Approval Pending!!!
WINNIPEG, June 25, 2020 /PRNewswire/ - Waverley Pharma Inc. ("Waverley Pharma" or the "Company") (TSXV:WAVE), an emerging Canadian pharmaceutical company, is pleased to announce it has entered into an Industrial Research Collaboration Agreement (the “Agreement”) with the University of Manitoba to undertake a research and development project entitled “Production of a Synthetic Library of Chloroquine Analogs and Precursors for Immediate and Future Development of COVID-19 Treatments.” The funding for this project is provided by the Natural Sciences and Engineering Research Council of Canada (NSERC) under its Alliance COVID-19 Grants program. Dr. David E. Herbert will serve as the Principal Investigator of the project. Dr. Herbert is currently an Associate Professor in the Department of Chemistry in addition to serving as the Faculty of Science Research Chair in Fundamental Science (Physical Sciences) at the University of Manitoba.